Citation Tools

Download PDFPDF

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial

Download to a citation manager

Cite this article as:
Maher TM, Corte TJ, Fischer A, et al
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial